Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease - PubMed (original) (raw)

Review

Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease

C Riddington et al. Cochrane Database Syst Rev. 2002.

Update in

Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease.
Hirst C, Owusu-Ofori S. Hirst C, et al. Cochrane Database Syst Rev. 2012 Sep 12;(9):CD003427. doi: 10.1002/14651858.CD003427.pub2. Cochrane Database Syst Rev. 2012. PMID: 22972063 Updated. Review.

Abstract

Background: People with sickle cell disease are particularly susceptible to infection. Infants and very young children are especially vulnerable, and the Cooperative Study of Sickle Cell Disease observed an incidence rate of 10 per 100 patient years of pneumococcal septicaemia in children under the age of three. Vaccines, including customary pneumococcal vaccines, may be of limited use in this age group. Therefore, prophylactic penicillin regimes may be advisable for this population.

Objectives: To assess the effects of prophylactic antibiotic regimes for preventing pneumococcal infection in children with sickle cell disease.

Search strategy: We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group specialist trials register which comprises references identified from comprehensive electronic database searches, hand searching relevant journals and hand searching abstract books of conference proceedings. Date of the most recent search: December 2001.

Selection criteria: All randomised or quasi-randomised controlled trials comparing prophylactic antibiotics to prevent pneumococcal infection in children with sickle cell disease with placebo, no treatment or a comparator drug.

Data collection and analysis: Both reviewers independently extracted data and assessed trial quality.

Main results: Five trials were identified by the initial search, of which three trials met the inclusion criteria. All of the included trials showed a reduced risk of infection in children with sickle cell disease (SS or Sb0Thal) receiving prophylactic penicillin. For initiation of treatment the odds ratio was 0.37 (95% CI 0.16, 0.86), and for withdrawal OR= 0.49 (95% CI 0.09, 2.71). Adverse drug effects were rare and minor. Rates of pneumococcal infection were found to be relatively low in children over the age of five.

Reviewer's conclusions: Prophylactic penicillin significantly reduces risk of pneumococcal infection in children with homozygous sickle cell disease, and is associated with minimal adverse reactions. Further research may help to determine the ideal age to safely withdraw penicillin.

PubMed Disclaimer

Cited by

The Use of HPLC as a Tool for Neonatal Cord Blood Screening of haemoglobinopathy: A Validation Study.
Al-Madhani A, Pathare A, Al Zadjali S, Al Rawahi M, Al-Nabhani I, Alkindi S. Al-Madhani A, et al. Mediterr J Hematol Infect Dis. 2019 Jan 1;11(1):e2019005. doi: 10.4084/MJHID.2019.005. eCollection 2019. Mediterr J Hematol Infect Dis. 2019. PMID: 30671211 Free PMC article.
Sickle cell disease in areas of immigration of high-risk populations: a low cost and reproducible method of screening in northern Italy.
Venturelli D, Lodi M, Palazzi G, Bergonzini G, Doretto G, Zini A, Monica C, Cano MC, Ilaria M, Montagnani G, Paolucci P. Venturelli D, et al. Blood Transfus. 2014 Jul;12(3):346-51. doi: 10.2450/2013.0188-13. Epub 2014 Mar 19. Blood Transfus. 2014. PMID: 24887233 Free PMC article.
Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease.
Rankine-Mullings AE, Owusu-Ofori S. Rankine-Mullings AE, et al. Cochrane Database Syst Rev. 2017 Oct 10;10(10):CD003427. doi: 10.1002/14651858.CD003427.pub4. Cochrane Database Syst Rev. 2017. PMID: 28994899 Free PMC article. Updated. Review.
Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease.
Rankine-Mullings AE, Owusu-Ofori S. Rankine-Mullings AE, et al. Cochrane Database Syst Rev. 2021 Mar 8;3(3):CD003427. doi: 10.1002/14651858.CD003427.pub5. Cochrane Database Syst Rev. 2021. PMID: 33724440 Free PMC article.
Psychosocial impact of sickle cell disorder: perspectives from a Nigerian setting.
Anie KA, Egunjobi FE, Akinyanju OO. Anie KA, et al. Global Health. 2010 Feb 20;6:2. doi: 10.1186/1744-8603-6-2. Global Health. 2010. PMID: 20170540 Free PMC article.

Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease - PubMed (original) (raw)